Is autoimmunity the Achilles' heel of cancer immunotherapy?

June, Carl H, Warshauer, Jeremy T, Bluestone, Jeffrey A·2017·Nature Medicine

DOI 10.1038/nm.4321

Cited by (445)

Items 201–300 of 445

Chimeric antigen receptor (CAR) immunotherapy: basic principles, current advances, and future prospects in neuro-oncology
Hyeon Joo Yoo, Biyan Nathanael Harapan · 2021 · Immunologic Research
The Continuum of Thyroid Disorders Related to Immune Checkpoint Inhibitors: Still Many Pending Queries
Maria V. Deligiorgi, Sofia Sagredou, Lampros Vakkas, Dimitrios T. Trafalis · 2021 · Cancers
Intestinal Microbiota and Gene Expression Reveal Similarity and Dissimilarity Between Immune-Mediated Colitis and Ulcerative Colitis
Kazuko Sakai, Toshiharu Sakurai, Marco Antonio De Velasco, Tomoyuki Nagai, Takaaki Chikugo, Kazuomi Ueshima, Yurie Kura, Takayuki Takahama, Hidetoshi Hayashi, Kazuhiko Nakagawa et al. · 2021 · Frontiers in Oncology
Pembrolizumab-Induced Fatal Myasthenia, Myocarditis, and Myositis in a Patient with Metastatic Melanoma: Autopsy, Histological, and Immunohistochemical Findings—A Case Report and Literature Review
Elena Giovannini, Maria Paola Bonasoni, Michele D’Aleo, Ione Tamagnini, Matteo Tudini, Paolo Fais, Susi Pelotti · 2023 · International Journal of Molecular Sciences
CTLA-4 Pathway Is Instrumental in Giant Cell Arteritis
Paul Régnier, Alexandre Le Joncour, Anna Maciejewski‐Duval, Guillaume Darrasse-Jèze, Charles Dolladille, Wouter C. Meijers, Lisa A. Bastarache, Pierre Jean Fouret, Patrick Bruneval, Floriane Arbaretaz et al. · 2023 · Circulation Research
Anti-PD-1 Immunotherapy in Preclinical GL261 Glioblastoma: Influence of Therapeutic Parameters and Non-Invasive Response Biomarker Assessment with MRSI-Based Approaches
Shuang Wu, Pilar Calero‐Pérez, Carles Arús, Ana Paula Candiota · 2020 · International Journal of Molecular Sciences
How does the gut microbiome influence immune checkpoint blockade therapy?
Almonte, Andrew A, Rangarajan, Hareesha, Yip, Desmond, Fahrer, Aude M · 2021 · Immunology & Cell Biology
Reprogramming of regulatory T cells in inflammatory tumor microenvironment: can it become immunotherapy turning point?
Jinming Liu, Biao Zhang, Guolin Zhang, Dong Shang · 2024 · Frontiers in Immunology
The Role of Gut Microbiota in Modulating Cancer Therapy Efficacy
Mostafa A. Madkour, Rawan A. Altaf, Zeinab S. Sayed, Noha S. Yasen, Hanan A. Elbary, Reem A. Elsayed, Esraa N. Mohamed, Mohamed Toema, Al-Hassan Soliman Wadan, Mohamed H. Nafady et al. · 2024 · Advanced Gut & Microbiome Research
Neurological immune-related adverse events with checkpoint inhibitor therapy: challenges for the neurologist
Mark D Willis, Benjamin E. Schroeder, Laura Marandino, Samra Turajlic, Aisling S. Carr · 2025 · Journal of Neurology Neurosurgery & Psychiatry
In situ vaccination using unique TLR9 ligand K3-SPG induces long-lasting systemic immune response and synergizes with systemic and local immunotherapy
Hirokazu Okada, Ken Takahashi, Hiroaki Yaku, Kouji Kobiyama, Keiko Iwaisako, Xiangdong Zhao, Masahiro Shiokawa, Norimitsu Uza, Yuzo Kodama, Ken J. Ishii et al. · 2022 · Scientific Reports
Clinical burden of immune checkpoint inhibitor-induced pneumonitis
Koji Sakamoto, Jun Fukihara, Masahiro Morise, Naozumi Hashimoto · 2020 · Respiratory Investigation
A Single-Chain-Based Hexavalent CD27 Agonist Enhances T Cell Activation and Induces Anti-Tumor Immunity
Meinolf Thiemann, David M. Richards, Karl Heinonen, Michael Kluge, Viola Marschall, Christian Merz, Mauricio Redondo Müller, Tim Schnyder, Julian P. Sefrin, Jaromir Sykora et al. · 2018 · Frontiers in Oncology
Cancer research in the era of immunogenomics
Yochai Wolf, Yardena Samuels · 2018 · ESMO Open
Pembrolizumab-Induced Psoriasis in Metastatic Melanoma: Activity and Safety of Apremilast, a Case Report
Maria Anna Siciliano, Stefano Dastoli, Maria D’Apolito, Nicoletta Staropoli, Pierfrancesco Tassone, Pierosandro Tagliaferri, Vito Barbieri · 2020 · Frontiers in Oncology
Microbiota-centered interventions to boost immune checkpoint blockade therapies
Almonte, Andrew A., Thomas, Simon, Zitvogel, Laurence · 2025 · Journal of Experimental Medicine
Mathematical modeling of intratumoral immunotherapy yields strategies to improve the treatment outcomes
Constantinos Harkos, Triantafyllos Stylianopoulos, Rakesh K. Jain · 2023 · PLoS Computational Biology
Combination Nivolumab/Ipilimumab Immunotherapy For Melanoma With Subsequent Unexpected Cardiac Arrest: A Case Report and Review of Literature
Zaid H. Khoury, Petr Frantisek Hausner, Cynthia L. Idzik-Starr, Matthew R.A. Frykenberg, John K Brooks, Donita Dyalram, John R. Basile, Rania H. Younis · 2019 · Journal of Immunotherapy
Association of Anti–Programmed Cell Death 1 Antibody Treatment With Risk of Recurrence of Toxic Effects After Immune-Related Adverse Events of Ipilimumab in Patients With Metastatic Melanoma
Angélique Brunot, Jean‐Jacques Grob, Géraldine Jeudy, Florent Grange, Bernard Guillot, N. Kramkimel, Laurent Mortier, Y. Le Corre, François Aubin, Sandrine Mansard et al. · 2020 · JAMA Dermatology
An ecosystem framework for understanding and treating disease
Michael Hochberg · 2018 · Evolution Medicine and Public Health
Promotion of ICD via Nanotechnology
Yang Qin, Haitao Zhang, Yunxian Li, Ting Xie, Shuang Yan, Jiaqi Wang, Jun Qu, Feijun Ouyang, Shaoyang Lv, Zifen Guo et al. · 2023 · Macromolecular Bioscience
Immunotherapy for early-stage non-small cell lung cancer: A system review
Jingyi Gao, Chao Zhang, Zhigang Wei, Xin Ye · 2023 · Journal of Cancer Research and Therapeutics
Ceria nanoparticles promoted the cytotoxic activity of CD8 + T cells by activating NF-κB signaling
Shupei Tang, Lan Zhou, Zhenyu Liu, Ling Zou, Minglu Xiao, Chunji Huang, Zhunyi Xie, Haiyang He, Yanyan Guo, Yi Cao et al. · 2019 · Biomaterials Science
Immune-Related Multiple-Organs Injuries Following ICI Treatment With Tislelizumab in an Advanced Non-Small Cell Lung Cancer Patient: A Case Report
Chao Deng, Meng Yang, Hong Jiang, Renbin Wang, Zhaojun Yang, Hongliang Sun, Huijuan Cui · 2021 · Frontiers in Oncology
mTOR‐dependent immunometabolism as Achilles' heel of anticancer therapy
C Braun, Thomas Weichhart · 2021 · European Journal of Immunology
Dynamic Imine Bonding Facilitates Mannan Release from a Nanofibrous Peptide Hydrogel
Brett H. Pogostin, Gabriel Saenz, Carson C. Cole, Erin M. Euliano, Jeffrey D. Hartgerink, Kevin J. McHugh · 2022 · Bioconjugate Chemistry
Erratum: Corrigendum: Is autoimmunity the Achilles' heel of cancer immunotherapy?
Carl H. June, Jeremy T. Warshauer, Jeffrey A. Bluestone · 2017 · Nature Medicine
Modulating the wayward T cell: New horizons with immune checkpoint inhibitor treatments in autoimmunity, transplant, and cancer
Leonard H. Calabrese, Roberto Felice Caporali, Christian U. Blank, Allan D. Kirk · 2020 · Journal of Autoimmunity
Reversible primary adrenal insufficiency related to anti-programmed cell-death 1 protein active immunotherapy: Insight into an unforeseen outcome of a rare immune-related adverse event
Maria V. Deligiorgi, Dimitrios T. Trafalis · 2020 · International Immunopharmacology
Biomarkers associated with immune-related adverse events induced by immune checkpoint inhibitors
An-Jie Guo, Qing-Yuan Deng, Pan Dong, Lian Zhou, Lei Shi · 2024 · World Journal of Clinical Oncology
Immune reconstitution and clinical recovery following anti-CD28 antibody (TGN1412)-induced cytokine storm
Panoskaltsis, Nicki, McCarthy, Neil E., Stagg, Andrew J., Mummery, Catherine J., Husni, Mariwan, Arebi, Naila, Greenstein, David, Price, Claire L., Al-Hassi, Hafid O., Koutinas, Michalis et al. · 2021 · Cancer Immunology, Immunotherapy
T cell help in the autoreactive germinal center
Elliot H. Akama‐Garren, Michael C. Carroll · 2022 · Scandinavian Journal of Immunology
ARTISTRY-7: phase III trial of nemvaleukin alfa plus pembrolizumab vs chemotherapy for platinum-resistant ovarian cancer
Thomas J. Herzog, John L. Hays, Joyce N. Barlin, Joseph Buscema, Noelle Gillette Cloven, Lynn R Kong, Nidhi Kumar Tyagi, Grainger S. Lanneau, Beverly J. Long, Robert L Marsh et al. · 2023 · Future Oncology
Advances in cancer diagnosis and therapy by alginate-based multifunctional hydrogels: A review
Ziwen Wang, Xu Han, Guowei Sun, Miao Yu, Juan Qin, Yuting Zhang, Ding Ding · 2024 · International Journal of Biological Macromolecules
Phytochemical Targeting of STAT3 Orchestrated Lipid Metabolism in Therapy-Resistant Cancers
Carmen Tse, Ashleigh Warner, Rufaik Farook, J. Cronin · 2020 · Biomolecules
Diabetes and susceptibility to infections: Implication for COVID‐19
Gustav van Niekerk, Michelle van der Merwe, Anna‐Mart Engelbrecht · 2021 · Immunology
Case Report: Glucocorticoid Effect Observation in a Ureteral Urothelial Cancer Patient With ICI-Associated Myocarditis and Multiple Organ Injuries
Xiajun Hu, Yumiao Wei, Xinxin Shuai · 2021 · Frontiers in Immunology
Pulmonary adverse events associated with hypertension in non-small cell lung cancer patients receiving PD-1/PD-L1 inhibitors
Jianing Chen, Yaokai Wen, Xiangling Chu, Yuzhi Liu, Chunxia Su · 2022 · Frontiers in Pharmacology
Distinct pretreatment innate immune landscape and posttreatment T cell responses underlie immunotherapy-induced colitis
Kazi Jannatun Nahar, Felix Marsh‐Wakefield, Robert V. Rawson, Tuba Nur Gide, Angela L. Ferguson, Ruth O. Allen, Camelia Y. J. Quek, Inês Pires da Silva, Stephen Tattersall, Christopher J. Kiely et al. · 2022 · JCI Insight
Impact of NSCLC metabolic remodeling on immunotherapy effectiveness
Lulu Lv, Ruo han Huang, Jiale Li, Jing Xu, Wen Gao · 2022 · Biomarker Research
Smart Design of Nanostructures for Boosting Tumor Immunogenicity in Cancer Immunotherapy
Bohan Yin, Wai‐Ki Wong, Yip Ming Ng, Mo Yang, Franco King‐Chi Leung, Siu Hong Dexter Wong · 2023 · Pharmaceutics
Effective antitumor peptide vaccines can induce severe autoimmune pathology
Hussein Sultan, Jimena Trillo-Tinoco, Paulo C. Rodrı́guez, Esteban Celis · 2017 · Oncotarget
Outcomes of Immune Checkpoint Inhibitor–related Diarrhea or Colitis in Cancer Patients With Superimposed Gastrointestinal Infections
Weijie Ma, Zimu Gong, Hamzah Abu‐Sbeih, Yuanzun Peng, Frederick B. Peng, Fangwen Zou, Aline Charabaty, Pablo C. Okhuysen, Jennifer Leigh McQuade, Mehmet Altan et al. · 2021 · American Journal of Clinical Oncology
Formatting and gene-based delivery of a human PD-L1 single domain antibody for immune checkpoint blockade
Robin Maximilian Awad, Quentin Lecocq, Katty Zeven, Thomas Ertveldt, Lien De Beck, Hannelore Ceuppens, Katrijn Broos, Yannick De Vlaeminck, Cleo Goyvaerts, Magali Verdonck et al. · 2021 · Molecular Therapy — Methods & Clinical Development
Neurological Adverse Events Induced by Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Current Perspectives and New Development
Ke Cheng, Yuqing Wang, Yuwen Zhou, Ruolan Xia, Liansha Tang, Jiyan Liu · 2021 · Clinical Medicine Insights Oncology
Soluble T-cell receptor design influences functional yield in an E. coli chaperone-assisted expression system
Kristin Støen Gunnarsen, Lene Støkken Høydahl, Ralf Stefan Neumann, Kaare Bjerregaard-Andersen, Nicolay Rustad Nilssen, Ludvig Magne Sollid, Inger Sandlie, Geir Åge Løset · 2018 · PLoS ONE
Autoimmune complications of cancer immunotherapy
Kavita M. Dhodapkar · 2019 · Current Opinion in Immunology
Recent advances in targeting protein degradation for tumor immunotherapy
Shuai Li, Yushan Jin, Huanhuan Wu, Hong Yuan, Jingyuan Zhao · 2025 · Journal of Hematology & Oncology
Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors
Gregory E. Sanda, Julie M. Shabto, Subir Goyal, Yuan Liu, Dylan J. Martini, Bassel Nazha, Jacqueline Theresa Brown, Lauren Beth Yantorni, Greta Anne Russler, Sarah E. Caulfield et al. · 2023 · The Oncologist
Dominant negative TGFβ receptor II and truncated TIM3 enhance the antitumor efficacy of CAR-T-cell therapy in prostate cancer
Lei Tang, Huimin Shao, Yao Wu, Jiawei Wang, Xueyi Qian, Lianjun He, Houbao Huang, Zhenyu Xu · 2023 · International Immunopharmacology
Advancing immunotherapy using biomaterials to control tissue, cellular, and molecular level immune signaling in skin
Shrey Shah, Robert S. Oakes, Christopher M. Jewell · 2024 · Advanced Drug Delivery Reviews
Checkpoint inhibitor-associated autoimmunity
Karim Ladak, Anne R. Bass · 2018 · Best Practice & Research Clinical Rheumatology
Multifunctional Nanocarriers‐Mediated Synergistic Combination of Immune Checkpoint Inhibitor Cancer Immunotherapy and Interventional Oncology Therapy
Bongseo Choi, Dong‐Hyun Kim · 2021 · Advanced NanoBiomed Research
The Adrenal Cortex and Its Disorders
Walter L. Miller, Christa E. Flück, David T. Breault, Brian J. Feldman · 2021 · Elsevier eBooks
Understanding the functional inflammatory factors involved in therapeutic response to immune checkpoint inhibitors for pan-cancer
Yanmeizhi Wu, Shan Yu, H. Qiao · 2022 · Frontiers in Pharmacology
Programmed cell death-1 and programmed cell death ligand-1 antibodies-induced dysthyroidism
Jaafar Jaafar, Eugenio Fernández, Heba Alwan, Jacques Philippé · 2018 · Endocrine Connections
The role and economics of immunotherapy in solid tumour management
Dominic Adam Worku, Victoria Hewitt · 2020 · Journal of Oncology Pharmacy Practice
IL-2 complex recovers steroid-induced inhibition in immunochemotherapy for head and neck cancer
Michihisa Kono, Hidekiyo Yamaki, Hiroki Komatsuda, Takumi Kumai, Ryusuke Hayashi, Risa Wakisaka, Ryosuke Sato, Kenzo Ohara, Kan Kishibe, Miki Takahara et al. · 2022 · Translational Oncology
Endocrine immune-related adverse effects of immune-checkpoint inhibitors
Viola Trevisani, Lorenzo Iughetti, Laura Lucaccioni, Barbara Predieri · 2023 · Expert Review of Endocrinology & Metabolism
Lighting up Self-Quenching Nanoaggregates with Protein Corona for Simultaneous Intraoperative Imaging and Photothermal Theranostics of Metastatic Cancer
Xueluer Mu, Wenbi Feng, Chunfeng Li, Kaixuan Li, Yajie Li, Xue Jing, Ying Lü, Xianfeng Zhou, Zhibo Li · 2022 · Analytical Chemistry
Cell surface‐nanoengineering for cancer targeting immunoregulation and precise immunotherapy
Yuhan Wang, Guojun Huang, Qi Hou, Hong Pan, Lintao Cai · 2022 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
Chimeric Antigen Receptor T-Cell Therapy: A Beacon of Hope in the Fight Against Cancer
Syed Maaz Tariq, Syed Ali Haider, Mohammad Hasan, Amber Tahir, Maria Khan, Arisha Rehan, Anum Kamal · 2018 · Cureus
Endocrine Adverse Events Related with Immune Checkpoint Inhibitors: An Update for Clinicians
Maria V. Deligiorgi, Mihalis I. Panayiotidis, Dimitrios T. Trafalis · 2020 · Immunotherapy
Non-bacterial cystitis caused by pembrolizumab therapy for adenocarcinoma of the lung: a case report
Caixia Di, Teng Yu, Lei Ni · 2024 · Frontiers in Immunology
Identification of Antigenic Targets
Hans‐Peter Gerber, Leah V. Sibener, Luke J. Lee, Marvin H. Gee · 2020 · Trends in cancer
Rheumatic complications in cancer patients treated with immune checkpoint inhibitors
Kyung‐Ann Lee, Hae‐Rim Kim, So Young Yoon · 2019 · The Korean Journal of Internal Medicine
Computational Models Accurately Predict Multi-Cell Biomarker Profiles in Inflammation and Cancer
Carol L. Fischer, Amber M. Bates, Emily Anne Lanzel, Janet M. Guthmiller, Georgia K. Johnson, Neeraj Kumar Singh, Ansu Kumar, Robinson Vidva, Taher Abbasi, Shireen Vali et al. · 2019 · Scientific Reports
The Roles of CD4+ T-Cells in Tumor Immunity
Soheil Tavakolpour, Mohammad Darvishi · 2020 · Springer eBooks
Cancer Immunoprevention: A Case Report Raising the Possibility of “Immuno-interception”
Jessica G. Mancuso, William David Foulkes, Michaël Pollak · 2020 · Cancer Prevention Research
Melanoma cells can be eliminated by sialylated CD43 × CD3 bispecific T cell engager formats in vitro and in vivo
Greta de Jong, Lina Bartels, Martijn Kedde, Els M.E. Verdegaal, Marijn Aletta Gillissen, Sophie E. Levie, Madalina G. Cercel, Susan E. van Hal-van Veen, Christien Fatmawati, Dorien van de Berg et al. · 2020 · Cancer Immunology Immunotherapy
Long-Term Antitumor CD8+ T Cell Immunity Induced by Endogenously Engineered Extracellular Vesicles
Flavia Ferrantelli, Francesco Manfredi, Chiara Chiozzini, Eleonora Olivetta, Andrea Giovannelli, Patrizia Leone, Maurizio Federico · 2021 · Cancers
Chemokine Pathways in Cutaneous Melanoma: Their Modulation by Cancer and Exploitation by the Clinician
Rebecca Adams, Bernhard Moser, Sophia N. Karagiannis, Katie E. Lacy · 2021 · Cancers
Checkpoint Inhibitor-Induced Autoimmune Diabetes: An Autoinflammatory Disease
Zoe Quandt, Ana Luisa Perdigoto, Mark S. Anderson, Kevan C. Herold · 2024 · Cold Spring Harbor Perspectives in Medicine
The pathogenesis of neurological immune-related adverse events following immune checkpoint inhibitor therapy
Magdalena Lerch, Sudarshini Ramanathan · 2025 · Seminars in Immunology
Diabetic ketoacidosis shortly after COVID ‐19 vaccination in a non–small‐cell lung cancer patient receiving combination of PD ‐1 and CTLA ‐4 inhibitors: A case report
Tomonori Makiguchi, Takashi Fukushima, Hisashi Tanaka, Kageaki Taima, Shinobu Takayasu, Sadatomo Tasaka · 2022 · Thoracic Cancer
Injectable zwitterionic cryogels for accurate and sustained chemoimmunotherapy
Jing Zhang, Lu Jie, Sunxiang Qian, Ni Haifeng, Jie Feng · 2023 · Journal of Materials Chemistry B
Focused ultrasound-mediated small-molecule delivery to potentiate immune checkpoint blockade in solid tumors
Qiuyu Wu, Yuanhang Xia, Xiaohe Xiong, Xinxing Duan, Xiaoxiao Pang, Fugui Zhang, Song Tang, Junlei Su, Shuqiong Wen, Li Mei et al. · 2023 · Frontiers in Pharmacology
Metastatic lymph node targeted CTLA4 blockade: a potent intervention for local and distant metastases with minimal ICI-induced pneumonia
Radhika Mishra, Ariunbuyan Sukhbaatar, Shiro Mori, Tetsuya Kodama · 2023 · Journal of Experimental & Clinical Cancer Research
Autoimmunity in 2017
Carlo Francesco Selmi · 2018 · Clinical Reviews in Allergy & Immunology
Bilateral Posterior Uveitis and Retinal Detachment During Immunotherapy: A Case Report and Literature Review
Ling Peng, Qiqi Mao, Bo Jiang, Jin Zhang, Yi-Lei Zhao, Xiaodong Teng, Jinsong Yang, Yang Xia, Shiqing Chen, Justin Stebbing et al. · 2020 · Frontiers in Oncology
Etiology and Pathogenesis of Diabetes Mellitus in Children and Adolescents
Mabel Yau, Noel Keith Maclaren, Mark A. Sperling · 2021 · Europe PMC (PubMed Central)
Regulation of Adaptive Tumor Immunity by Non-Coding RNAs
Eleftheria Papaioannou, María del Pilar González-Molina, Ana M. Prieto-Muñoz, Laura Gámez-Reche, Alicia González-Martín · 2021 · Cancers
The Immune Microenvironment in Liver Cancer: From Analysis to Targeting
Jiaming Lan, Hao Li, Jian Xue, Yourong Duan, Jin Sun, Meng Niu · 2025 · Advanced Science
Current landscape and tailored management of immune-related adverse events
Wenhui Liu, Zhiying Luo, Yiping Liu, Bao Sun · 2023 · Frontiers in Pharmacology
Engineering Living Immunotherapeutic Agents for Improved Cancer Treatment
Tinotenda Gwisai, Sina Günther, Nima Mirkhani, Matej Vizovišek, Stefano Menghini, Mira Jacobs, Michael G. Christiansen, Ines Oberhuber, Pascal Poc, Simone Schuerle · 2023 · Advanced Therapeutics
Crystal structure of an L chain optimised 14F7 anti-ganglioside Fv suggests a unique tumour-specificity through an unusual H-chain CDR3 architecture
Kaare Bjerregaard-Andersen, Hedda Johannesen, Noha Abdel‐Rahman, Julie Elisabeth Heggelund, Helene Mykland Hoås, Fana Abraha, Paula Anna Bousquet, Lene Støkken Høydahl, D. Burschowsky, Gertrudis Rojas et al. · 2018 · Scientific Reports
Bioinspired tissue-compliant hydrogels with multifunctions for synergistic surgery–photothermal therapy
Wenwen Jiang, Yuzhong Chen, Lin Zhao, Jiaying Xu, Rui Jie Zhao, Michael J. Serpe, Liang Hu · 2020 · Journal of Materials Chemistry B
Precision Tools in Immuno-Oncology: Synthetic Gene Circuits for Cancer Immunotherapy
Giuliano Bonfá, Juan Luis Blazquez-Roman, Rita Tarnai, Velia Siciliano · 2020 · Vaccines
Bibliometric analysis of rheumatic immune related adverse events associated with immune checkpoint inhibitors
Li Zeng, Gang Ma, Kai Chen, Qiao Zhou · 2023 · Frontiers in Immunology
Association between immune‐related adverse events and prognosis in patients treated with immune checkpoint inhibitors in melanoma: A surrogacy analysis
Romain Euvrard, Marie Robert, Sabine Mainbourg, Stéphane Dalle, Jean‐Christophe Lega · 2023 · Fundamental and Clinical Pharmacology
Blocking Effect of Chaga Mushroom (Inonotus oliquus) Extract for Immune Checkpoint CTLA-4/CD80 Interaction
Tae In Kim, Jang‐Gi Choi, Ji Hye Kim, Wei Li, Hwan‐Suck Chung · 2020 · Applied Sciences
Rheumatic and musculoskeletal disorders induced by immune checkpoint inhibitors: Consequences on overall survival
Leslie Adda, Benjamin Batteux, Zuzana Saidak, Claire Poulet, Jean‐Philippe Arnault, Bruno Chauffert, Alice Séjourné · 2021 · Joint Bone Spine
Keeping the Engine Running: The Relevance and Predictive Value of Preclinical Models for CAR-T Cell Development
Denis Migliorini, Nicola J. Mason, Avery D. Posey · 2018 · ILAR Journal
Pembrolizumab in a Patient With Heavily Pre-Treated Squamous Cell Thymic Carcinoma and Cardiac Impairment: A Case Report and Literature Review
Alessandro Cafaro, Alberto Bongiovanni, Valentina Di Iorio, Devil Oboldi, Carla Masini, Toni Ibrahim · 2020 · Frontiers in Oncology
The evolving landscape of immune‐related adverse events that follow immune checkpoint immunotherapy in cancer patients
Alexandra–Chloé Villani · 2023 · Immunological Reviews
Leveraging cryoablation and checkpoint inhibitors for high-risk triple negative breast cancer
Flávia Sardela de Miranda, Maribel Castro, Nicole Remmert, Sharda Prakash Singh, Rakhshanda Layeequr Rahman, Michael W. Melkus · 2023 · Frontiers in Immunology
PD-1, BTLA and TIGIT as therapeutic targets for rheumatic disease
Juhi R. Kuchroo, Naomi Goldman, Arlene H. Sharpe · 2025 · Nature Reviews Rheumatology
BOIN: a novel Bayesian design platform to accelerate early phase brain tumor clinical trials
Ying Yuan, Jing Wu, Mark R. Gilbert · 2021 · Neuro-Oncology Practice
Heterogeneous multi-compartmental DNA hydrogel particles prepared via microfluidic assembly for lymphocyte-inspired precision medicine
Sophie Wan Mei Lian, Song Guo, Kewei Ren, Ying Cao Xu, John S. Ho, Chia‐Hung Chen · 2021 · Nanoscale
Impact of CTLA-4 checkpoint antibodies on ligand binding and Transendocytosis
Cayman Williams, Alan Kennedy, Maximillian A Robinson, Christopher Lloyd, Simon J. Dovedi, David Michael Sansom · 2022 · Frontiers in Immunology